FUS mutations dominate TBK1 mutations in FUS/TBK1 double-mutant ALS/FTD pedigrees.

"Declarations Ethics approval/consent to participate/consent for publicationThe study was approved by the medical ethical review boards of the universities of Ulm and Umea. Written informed consent for participation and publication was obtained in accordance with institutional requirements and the study fulfilled the principles of the Declaration of Helsinki. Conflict of interestThe authors declare no competing interests. Conflict of interest The authors declare no competing interests."

"Funding Open Access funding enabled and organized by Projekt DEAL. This work was supported in whole or in part by grants of the Medical Faculty Mannheim of the University of Heidelberg (Mannheim Advanced Clinician Scientist [MACS] program), the Medical Faculty of the University of Ulm (Clinician Scientist Baustein program), the Charcot Foundation for ALS research (Ulm), the German society for patients with muscular diseases (DGM), and the German Federal Ministry of Education and Research (JPND ‘STRENGTH’ consortium [01ED1408]; JPND ‘PreFrontAls’ [01ED1512]; the German Network for ALS Research MND-NET [01GM1103A])."